156 related articles for article (PubMed ID: 36621191)
1. Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation.
Saxena S; Jena B; Mohapatra B; Gupta N; Kalra M; Scartozzi M; Saba L; Suri JS
Comput Biol Med; 2023 Feb; 153():106492. PubMed ID: 36621191
[TBL] [Abstract][Full Text] [Related]
2. Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach.
Do DT; Yang MR; Lam LHT; Le NQK; Wu YW
Sci Rep; 2022 Aug; 12(1):13412. PubMed ID: 35927323
[TBL] [Abstract][Full Text] [Related]
3. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive O
Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M
World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292
[TBL] [Abstract][Full Text] [Related]
5. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
Xi YB; Guo F; Xu ZL; Li C; Wei W; Tian P; Liu TT; Liu L; Chen G; Ye J; Cheng G; Cui LB; Zhang HJ; Qin W; Yin H
J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163
[TBL] [Abstract][Full Text] [Related]
6. Development of A Radiomic Model for
Doniselli FM; Pascuzzo R; Agrò M; Aquino D; Anghileri E; Farinotti M; Pollo B; Paterra R; Cuccarini V; Moscatelli M; DiMeco F; Sconfienza LM
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203308
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Three Different Deep Learning-Based Models to Predict the MGMT Promoter Methylation Status in Glioblastoma Using Brain MRI.
Faghani S; Khosravi B; Moassefi M; Conte GM; Erickson BJ
J Digit Imaging; 2023 Jun; 36(3):837-846. PubMed ID: 36604366
[TBL] [Abstract][Full Text] [Related]
8. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
Korfiatis P; Kline TL; Coufalova L; Lachance DH; Parney IF; Carter RE; Buckner JC; Erickson BJ
Med Phys; 2016 Jun; 43(6):2835-2844. PubMed ID: 27277032
[TBL] [Abstract][Full Text] [Related]
9. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
Kanas VG; Zacharaki EI; Thomas GA; Zinn PO; Megalooikonomou V; Colen RR
Comput Methods Programs Biomed; 2017 Mar; 140():249-257. PubMed ID: 28254081
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
11. MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
Yamashita S; Yokogami K; Matsumoto F; Saito K; Mizuguchi A; Ohta H; Takeshima H
J Neurosurg; 2018 May; 130(3):780-788. PubMed ID: 29726772
[TBL] [Abstract][Full Text] [Related]
12. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB
BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012
[TBL] [Abstract][Full Text] [Related]
13. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
[TBL] [Abstract][Full Text] [Related]
14. Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach.
Crisi G; Filice S
J Neuroimaging; 2020 Jul; 30(4):458-462. PubMed ID: 32374045
[TBL] [Abstract][Full Text] [Related]
15. Radiogenomic classification for MGMT promoter methylation status using multi-omics fused feature space for least invasive diagnosis through mpMRI scans.
Qureshi SA; Hussain L; Ibrar U; Alabdulkreem E; Nour MK; Alqahtani MS; Nafie FM; Mohamed A; Mohammed GP; Duong TQ
Sci Rep; 2023 Feb; 13(1):3291. PubMed ID: 36841898
[TBL] [Abstract][Full Text] [Related]
16. MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning models.
Saeed N; Ridzuan M; Alasmawi H; Sobirov I; Yaqub M
Med Image Anal; 2023 Dec; 90():102989. PubMed ID: 37827111
[TBL] [Abstract][Full Text] [Related]
17. The significance of MGMT methylation in Glioblastoma Multiforme prognosis.
Rao AM; Quddusi A; Shamim MS
J Pak Med Assoc; 2018 Jul; 68(7):1137-1139. PubMed ID: 30317322
[TBL] [Abstract][Full Text] [Related]
18. Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis.
Chen X; Zeng M; Tong Y; Zhang T; Fu Y; Li H; Zhang Z; Cheng Z; Xu X; Yang R; Liu Z; Wei X; Jiang X
Biomed Res Int; 2020; 2020():9258649. PubMed ID: 33029531
[TBL] [Abstract][Full Text] [Related]
19. AI-driven estimation of O6 methylguanine-DNA-methyltransferase (MGMT) promoter methylation in glioblastoma patients: a systematic review with bias analysis.
Samartha MVS; Dubey NK; Jena B; Maheswar G; Lo WC; Saxena S
J Cancer Res Clin Oncol; 2024 Jan; 150(2):57. PubMed ID: 38291266
[TBL] [Abstract][Full Text] [Related]
20. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
